MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » CardioFocus, China Grand Pharmaceutical partner to commercialize catheter ablation system in China

CardioFocus, China Grand Pharmaceutical partner to commercialize catheter ablation system in China

By

CardioFocusCardioFocus China Grand Pharmaceutical today announced a licensing and distribution agreement with China Grand Pharmaceutical to seek regulatory approvals for the HeartLight X3 catheter ablation technology in China.

Marlborough, Mass.–based CardioFocus designed the HeartLight X3 system for controlled and consistent pulmonary vein isolation, which is the primary treatment for atrial fibrillation (AFib).

Get the full story on our sister site, Medical Tubing + Extrusion.

More recent news

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].